Literature DB >> 7312833

A simplified procedure for purification of human prothrombin, factor IX and factor X.

S P Bajaj, S I Rapaport, C Prodanos.   

Abstract

A simplified procedure is described for the purification of prothrombin, Factor X and Factor IX in overall yields of 35-40% from pooled human plasma. The initial steps, which are common to prior purification techniques, include adsorption onto and elution from barium citrate, ammonium sulfate fractionation, and DEAE-Sephadex chromatography. The procedure differs from previous techniques in that the nest step, heparin-agarose chromatography, is carried out in a (sodium) citrate buffer, pH 7.5. These chromatographic conditions permit the separation of prothrombin, Factor X and Factor IX from each other, yielding fractions with apparent homogeneity in several electrophoretic systems. The additional chromatographic steps of earlier purification procedures are therefore unnecessary. The heaprin-agrarose column chromatographic conditions consistently resulted in the separation of human prothrombin in into two fractions in a ratio of approximately 4:1. Both fractions possess similar specific activity in a one stage prothrombin assay, and also activate at the same rate in a Factor Xa, Ca2+ and phospholipid system. Both fractions of prothrombin also comigrate in sodium dodecyl sulfate gel electrophoresis with an apparent Mr integral of 70,000.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7312833     DOI: 10.1080/00327488108065531

Source DB:  PubMed          Journal:  Prep Biochem        ISSN: 0032-7484


  32 in total

1.  Factor VIIa binding and internalization in hepatocytes.

Authors:  G Hjortoe; B B Sorensen; L C Petersen; L V M Rao
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

2.  A novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma.

Authors:  P K Ngai; J Y Chang
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

3.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

4.  Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

Authors:  S P Bajaj; A K Sabharwal; J Gorka; J J Birktoft
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

5.  Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.

Authors:  G J Broze; J P Miletich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain.

Authors:  M Van Wijnen; J G Stam; G T Chang; J C Meijers; P H Reitsma; R M Bertina; B N Bouma
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

8.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

9.  The influence of von Willebrand factor on factor VIII activity measurements.

Authors:  S Butenas; B Parhami-Seren; K G Mann
Journal:  J Thromb Haemost       Date:  2008-10-29       Impact factor: 5.824

10.  First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

Authors:  D Zhong; K J Smith; J J Birktoft; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.